Abstract:Objective To investigate our experience in the diagnosis and treatment of acute graft-versus-host disease（a GVHD） after liver transplantation in surgical ICU. Methods We retrospectively analyzed the general data,clinical manifestation,diagnosis,and treatment strategies of five patients with a GVHD after liver transplantation in The First Affiliated Hospital of Xi’an Jiaotong University from January 2000 to December 2019. Results The incidence rate of a GVHD was 5/850（5.88 ‰）, and all the five patients were male and aged 40-64 years（mean age56 years）. Diabetes, hepatocellular carcinoma, liver transplantation, transcatheter arterial chemoembolization（TACE）, and high concentration of immune agents were the main risk factors associated with the development of aG VHD. The average time from surgery until clinical symptom of aG VHD was 15 to 32 days. In our patients with aG VHD, the most common symptom was fever（5/5）, followed by skin rash（5/5）, pancytopenia（5/5）, diarrhea（3/5）, and secondary pulmonary infection（3/5）. However, liver functions were not remarkable affected. Diagnostic criteria for aG VHD in our center include acute onset, risk factors, typical clinical manifestation, and histopathology after exclusion of differential diseases. Our treatment strategies include high-dose methylprednisolone, stopping/reducing current immunosuppressive protocol, and antilymphocytic agents as secondline treatment. Empirical antibiotics and antifungal agents play a vital part in infections after transplantation. Hematopoietic cytokine was administered to treat pancytopenia. Patients also received supportive therapy, such as isolation and nutritional support, with the goal of benefiting the entire condition. Despite intensive treatment, two of five patients（40%） with aG VHD died due to sepsis and multiorgan failure. One case（20%） died of intracranial hemorrhage and one case（20%） died of tuberculosis. Only one case（20%） stayed alive after 1-year follow-up without complications. Conclusion The diagnosis of aG VHD relies on clinical suspicion and is confirmed by skin pathology. The patients with aG VHD had early onset（＜30 day）, high peak temperature（＞38.5 ℃）, large rash range（＞50%）, complication of sepsis,and poor response to hematopoietic cytokine therapy indicate poor prognosis. Intensive treatment should be started immediately after aG VHD diagnosis. In conclusion, we strongly suggest an early identification, diagnosis, and vigorous treatment strategy, which is the key to improving the prognosis of aG VHD.

Late Onset of Severe Graft‐versus‐host Disease Following Liver Transplantation

[Graft Versus Host Disease after Liver Transplantation: a Report of 3 Cases].

Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases

Acute Graft-vs-Host Disease After Liver Transplantation in a Patient Presenting With Neurogenic Symptoms as the Single Primary Manifestation: A Case Report.

PRELIMINARY CHINICAL EXPERIENCE OF LIVER TRANSPLANT-ASSOCIATED GRAFT-VERSUS-HOST DISEASE.

Transplant Associated Graft versus Host Disease

Progress of the Giagnosis and Treatment of Postoperative Liver Transplant-Associated Graft Versus Host Disease

Diagnosis and Treatment of Graft Versus Host Disease after Liver Transplantation

Experience in Diagnosis and Treatment of Acute Graft-Versus-host Disease after Liver Transplantation of Five Cases

Transfusion-associated Graft-Versus-host-disease: Case Report and Review of Literature

S2548 Acute Graft vs Host Disease Presenting as Biliary Obstruction: A Rare Complication Following Allogeneic Stem Cell Transplantation

[Exploration of Acute Graft Versus Host Disease and Its Risk Factors after Allo-Hematopoietic Stem Cell Transplantation].

Fatal graft-versus-host disease in recipient with pretransplant exposure to immune checkpoint inhibitors and donor-dominant one-way HLA matching after liver transplantation: A case report

Graft-Versus-Host Disease: Challenges For Diagnosis And Treatment.

[Effect of Graft-Versus-host Disease on Relapse and Survival in 100 Patients after Allogeneic Hematopoietic Stem Cell Transplantation].

Chronic graft-versus-host disease: Pathogenesis and clinical management

Diagnosis And Differential Diagnosis Of Hepatic Graft Versus Host Disease (Gvhd)

Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation

Graft Failure from Hepatic Veno-Occlusive Disease after A Liver Transplant: A Case Report

Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program.

[Analysis of Risk Factors for the Development of Acute Graft-Versus-host Disease in 151 Cases of Allo-Hematopoietic Stem Cell Transplantation].